FTC Reconsidering Drug Chains' Divestiture Strategies - Commission's Balto
This article was originally published in The Rose Sheet
Executive Summary
The Federal Trade Commission is reconsidering its traditional strategy of requiring the divestiture of store locations before approving drug chain mergers, FTC Bureau of Competition Office of Policy and Evaluation Assistant Director David Balto told the National Association of Chain Drug Stores Aug. 31.